查看购物车
  • Traditional Chinese
  • English
  • Japanese
封面
市场调查报告书
商品编码
1705230

2025年切片检查全球市场报告

Kidney Biopsy Global Market Report 2025
出版日期: | 出版商: The Business Research Company | 英文 200 Pages | 商品交期: 2-10个工作天内

价格
简介目录

预计未来几年切片检查市场规模将强劲成长。到 2029 年，这一数字将成长至 28 亿美元，复合年增长率为 5.4%。预测期内的增长归因于肾臟疾病盛行率的增加、医疗保健支出的增加、对早期诊断的认识的提高、老年人口的增加、对微创手术的需求的增加以及研究活动的活性化。预测期内的关键趋势包括切片检查技术的进步、微创技术的采用、成像技术的进步、人工智慧的整合以提高准确性以及切片检查设备的创新。

肾癌发生率的不断上升将推动切片检查市场的成长。肾癌涉及异常肾细胞不受控制的生长，受到生活方式改变、环境毒素和改进的诊断方法等因素的影响，导致检出率很高。肾臟切片检查在肾癌的诊断和治疗中起着关键作用，可以确认癌细胞的存在、确定癌症的阶段、指导治疗策略、监测治疗反应并提供预后见解。例如，英国癌症研究中心预测，新的肾癌病例将从 2023 年的约 16,300 例增加到 2025 年的约 21,900 例，这将导致对切片检查服务的需求增加。

切片检查市场的主要企业正在透过整合人工智慧 (AI) 进行创新，以提高诊断准确性、简化程序并优化患者结果。人工智慧技术透过增强影像解释、支援诊断决策、协助治疗计划、提供预测分析和推进肾臟疾病研究来改善肾臟切片检查分析。例如，荷兰软体公司Aiosyn于2024年3月推出了NephroPath平台。该平台利用计算病理学演算法分析肾臟切片检查中的组织学生物标誌物，包括组织学类型的识别、间质纤维化的测量以及肾小球的精确量化和评估。这种由人工智慧主导的分析确保了对肾臟病理生物标记的一致、详细和可重复的评估，克服了传统评分方法的局限性并降低了观察者的主观性。

目录

第一章执行摘要

第二章 市场特征

第三章 市场趋势与策略

第四章 市场 - 宏观经济情景，包括利率、感染疾病、地缘政治、新冠疫情和经济復苏对市场的影响

第五章 全球成长分析与策略分析框架

  • 全球肾臟切片检查PESTEL分析（政治、社会、技术、环境、法律因素、驱动因素与限制因素）
  • 最终用途产业分析
  • 全球切片检查市场：成长率分析
  • 全球切片检查市场表现：规模与成长，2019-2024
  • 全球切片检查市场预测：2024-2029 年及 2034 年规模与成长
  • 全球切片检查总目标市场（TAM）

第六章市场区隔

  • 全球切片检查市场类型、绩效及预测（2019-2024、2024-2029、2034）
  • 切片检查
  • 手术切片检查
  • 全球切片检查市场（依适应症、绩效及预测），2019-2024 年、2024-2029 年、2034 年
  • 肾衰竭
  • 肾臟移植
  • 血尿
  • 蛋白尿
  • 全球切片检查市场（按最终用户、绩效及预测）2019-2024、2024-2029、2034
  • 医院和诊所
  • 泌尿系统中心
  • 三级医疗中心
  • 其他的
  • 全球切片检查市场、经皮细分市场、类型、绩效及预测（2019-2024、2024-2029、2034）
  • 超音波引导下切片检查
  • CT引导下切片检查
  • MRI导引下切片检查
  • 全球切片检查市场、手术切片检查细分、类型、绩效及预测（2019-2024、2024-2029、2034）
  • 开放性肾臟切片检查
  • 腹腔镜切片检查

第七章 区域和国家分析

  • 全球切片检查市场：按地区、绩效及预测，2019-2024、2024-2029、2034
  • 全球切片检查市场：依国家、表现及预测，2019-2024 年、2024-2029 年、2034 年

第八章 亚太市场

第九章：中国市场

第十章 印度市场

第十一章 日本市场

第十二章 澳洲市场

第十三章 印尼市场

第十四章 韩国市场

第十五章 西欧市场

第十六章英国市场

第十七章 德国市场

第十八章 法国市场

第十九章：义大利市场

第20章：西班牙市场

第21章 东欧市场

第22章 俄罗斯市场

第23章 北美市场

第24章美国市场

第25章：加拿大市场

第26章 南美洲市场

第27章：巴西市场

第28章 中东市场

第29章：非洲市场

第30章竞争格局与公司概况

  • 切片检查切片市场：竞争格局
  • 切片检查切片市场：公司简介
    • Cardinal Health
    • Pfizer Inc.
    • Merck & Co. Inc.
    • Thermo Fisher Scientific Inc.
    • AstraZeneca

第31章 其他大型创新企业

  • Medtronic
  • Siemens Healthcare Private Limited
  • Becton, Dickinson and Company
  • Stryker Healthcare
  • Baxter International Inc.
  • Boston Scientific Corporation
  • F. Hoffmann-La Roche Ltd.
  • Zimmer Biomet
  • Agilent Technologies Inc.
  • Olympus Corporation
  • Hitachi High-Tech Corporation
  • Beckman Coulter Inc.
  • B. Braun
  • Sysmex Corporation
  • Cook Medical

第 32 章全球市场竞争基准化分析与仪表板

第33章 重大併购

第34章近期市场趋势

第35章：市场潜力大的国家与策略

  • 2029年切片检查市场：提供新机会的国家
  • 2029年切片检查市场：细分领域带来新机会
  • 2029年切片检查市场：成长策略
    • 基于市场趋势的策略
    • 竞争对手的策略

第36章 附录

简介目录
Product Code: r30537

A kidney biopsy, also referred to as a renal biopsy, is a medical procedure where a small sample of kidney tissue is extracted for microscopic analysis. This procedure is commonly conducted to diagnose kidney conditions, evaluate the severity of existing kidney diseases, or monitor treatment effectiveness. It plays a crucial role in identifying diverse kidney disorders such as glomerulonephritis, interstitial nephritis, and nephrotic syndrome, offering insights into the underlying causes of kidney dysfunction.

The primary types of kidney biopsy include percutaneous biopsy and surgical biopsy. Percutaneous biopsy involves inserting a needle through the skin to obtain tissue samples from the kidney for examination. This method is utilized in various clinical settings including cases of kidney failure, kidney transplantation, hematuria, and proteinuria. It is employed by hospitals, clinics, urology centers, tertiary care centers, and other healthcare facilities.

The kidney biopsy market research report is one of a series of new reports from The Business Research Company that provides kidney biopsy market statistics, including the kidney biopsy industry global market size, regional shares, competitors with kidney biopsy market share, detailed kidney biopsy market segments, market trends, and opportunities, and any further data you may need to thrive in the kidney biopsy industry. These kidney biopsy market research reports deliver a complete perspective of everything you need, with an in-depth analysis of the current and future scenarios of the industry.

The kidney biopsy market size has grown strongly in recent years. It will grow from $2.14 billion in 2024 to $2.27 billion in 2025 at a compound annual growth rate (CAGR) of 5.8%. The growth in the historic period can be attributed to increased chronic kidney diseases, rise in awareness about early diagnosis, surge in geriatric population, expansion of healthcare infrastructure, enhanced government initiatives for kidney disease management, and rise in awareness of kidney health.

The kidney biopsy market size is expected to see strong growth in the next few years. It will grow to $2.8 billion in 2029 at a compound annual growth rate (CAGR) of 5.4%. The growth in the forecast period can be attributed to increasing prevalence of kidney diseases, rising healthcare expenditure, growing awareness about early diagnosis, expanding geriatric population, rising demand for minimally invasive procedures, and increasing research activities. Major trends in the forecast period include technological advancements in biopsy techniques, adoption of minimally invasive procedures, advancements in imaging technologies, integration of artificial intelligence for better precision, and technological innovations in biopsy devices.

The increasing incidence of renal cancer is poised to drive growth in the kidney biopsy market. Renal cancer involves the unchecked proliferation of abnormal kidney cells, influenced by factors such as lifestyle changes, environmental toxins, and improved diagnostic methods leading to higher detection rates. Kidney biopsies play a crucial role in diagnosing and managing renal cancer by confirming the presence of cancerous cells, determining cancer stage, guiding treatment strategies, monitoring treatment response, and providing prognostic insights. For example, Cancer Research UK projects an anticipated rise in new kidney cancer cases from approximately 16,300 in 2023 to about 21,900 by 2025, underscoring the escalating demand for kidney biopsy services.

Leading companies in the kidney biopsy market are innovating by integrating artificial intelligence (AI) to enhance diagnostic precision, streamline procedures, and optimize patient outcomes. AI technology improves kidney biopsy analysis by enhancing image interpretation, supporting diagnostic decisions, assisting in treatment planning, offering predictive analytics, and advancing research in kidney diseases. For instance, Aiosyn, a Netherlands-based software firm, introduced the NephroPath platform in March 2024. This platform utilizes computational pathology algorithms to analyze histological biomarkers in kidney biopsies, including tissue type identification, measurement of interstitial fibrosis, and precise quantification and evaluation of glomeruli. Such AI-driven analysis ensures consistent, detailed, and reproducible assessment of renal pathology biomarkers, overcoming limitations associated with traditional scoring methods and reducing observer subjectivity.

In October 2022, Halma plc, a UK-based technology company, acquired IZI Medical Products for $176 million. This strategic acquisition enhances Halma plc's footprint in the kidney biopsy sector by integrating IZI Medical's advanced core biopsy devices. These devices are utilized across various anatomical sites, including kidneys, thyroid, intra-abdominal areas, and liver, aimed at improving the safety, accuracy, and efficacy of biopsy procedures. This acquisition underscores Halma plc's commitment to advancing biopsy technologies to benefit both patients and healthcare providers.

Major companies operating in the kidney biopsy market are Cardinal Health, Pfizer Inc., Merck & Co. Inc., Thermo Fisher Scientific Inc., AstraZeneca, Medtronic, Siemens Healthcare Private Limited, Becton, Dickinson and Company, Stryker Healthcare, Baxter International Inc., Boston Scientific Corporation, F. Hoffmann-La Roche Ltd., Zimmer Biomet, Agilent Technologies Inc., Olympus Corporation, Hitachi High-Tech Corporation, Beckman Coulter Inc., B. Braun, Sysmex Corporation, Cook Medical, Bio-Rad Laboratories Inc., Integra LifeSciences Corporation, Merit Medical Systems, Leica Biosystems Nussloch GmbH, Argon Medical Devices Inc., BioGenex

North America was the largest region in the kidney biopsy market in 2024. Asia-Pacific is expected to be the fastest-growing region in the forecast period. The regions covered in the kidney biopsy market report are Asia-Pacific, Western Europe, Eastern Europe, North America, South America, Middle East, Africa.

The countries covered in the kidney biopsy market report are Australia, Brazil, China, France, Germany, India, Indonesia, Japan, Russia, South Korea, UK, USA, Canada, Italy, Spain.

The kidney biopsy market consists of revenues earned by entities by providing services such as diagnostic biopsy, therapeutic biopsy, post-biopsy care and monitoring, and pathological analysis. The market value includes the value of related goods sold by the service provider or included within the service offering. The kidney biopsy market also includes sales of biopsy needles, biopsy guns, biopsy trays and kits, and biopsy specimen containers. Values in this market are 'factory gate' values, that is the value of goods sold by the manufacturers or creators of the goods, whether to other entities (including downstream manufacturers, wholesalers, distributors and retailers) or directly to end customers. The value of goods in this market includes related services sold by the creators of the goods.

The market value is defined as the revenues that enterprises gain from the sale of goods and/or services within the specified market and geography through sales, grants, or donations in terms of the currency (in USD, unless otherwise specified).

The revenues for a specified geography are consumption values that are revenues generated by organizations in the specified geography within the market, irrespective of where they are produced. It does not include revenues from resales along the supply chain, either further along the supply chain or as part of other products.

Kidney Biopsy Global Market Report 2025 from The Business Research Company provides strategists, marketers and senior management with the critical information they need to assess the market.

This report focuses on kidney biopsy market which is experiencing strong growth. The report gives a guide to the trends which will be shaping the market over the next ten years and beyond.

Reasons to Purchase

  • Gain a truly global perspective with the most comprehensive report available on this market covering 15 geographies.
  • Assess the impact of key macro factors such as conflict, pandemic and recovery, inflation and interest rate environment and the 2nd Trump presidency.
  • Create regional and country strategies on the basis of local data and analysis.
  • Identify growth segments for investment.
  • Outperform competitors using forecast data and the drivers and trends shaping the market.
  • Understand customers based on the latest market shares.
  • Benchmark performance against key competitors.
  • Suitable for supporting your internal and external presentations with reliable high quality data and analysis
  • Report will be updated with the latest data and delivered to you within 2-3 working days of order along with an Excel data sheet for easy data extraction and analysis.
  • All data from the report will also be delivered in an excel dashboard format.

Where is the largest and fastest growing market for kidney biopsy ? How does the market relate to the overall economy, demography and other similar markets? What forces will shape the market going forward? The kidney biopsy market global report from the Business Research Company answers all these questions and many more.

The report covers market characteristics, size and growth, segmentation, regional and country breakdowns, competitive landscape, market shares, trends and strategies for this market. It traces the market's historic and forecast market growth by geography.

  • The market characteristics section of the report defines and explains the market.
  • The market size section gives the market size ($b) covering both the historic growth of the market, and forecasting its development.
  • The forecasts are made after considering the major factors currently impacting the market. These include:

The forecasts are made after considering the major factors currently impacting the market. These include the Russia-Ukraine war, rising inflation, higher interest rates, and the legacy of the COVID-19 pandemic.

  • Market segmentations break down the market into sub markets.
  • The regional and country breakdowns section gives an analysis of the market in each geography and the size of the market by geography and compares their historic and forecast growth. It covers the growth trajectory of COVID-19 for all regions, key developed countries and major emerging markets.
  • The competitive landscape chapter gives a description of the competitive nature of the market, market shares, and a description of the leading companies. Key financial deals which have shaped the market in recent years are identified.
  • The trends and strategies section analyses the shape of the market as it emerges from the crisis and suggests how companies can grow as the market recovers.

Scope

  • Markets Covered:1) By Type: Percutaneous Biopsy; Surgical Biopsy
  • 2) By Indication: Kidney Failure; Kidney Transplant; Hematuria; Proteinuria
  • 3) By End-User: Hospitals And Clinics; Urology Centers; Tertiary Care Centers; Other End-Users
  • Subsegments:
  • 1) By Percutaneous Biopsy: Ultrasound-Guided Biopsy; CT-Guided Biopsy; MRI-Guided Biopsy
  • 2) By Surgical Biopsy: Open Kidney Biopsy; Laparoscopic Kidney Biopsy
  • Companies Mentioned: Cardinal Health; Pfizer Inc.; Merck & Co. Inc.; Thermo Fisher Scientific Inc.; AstraZeneca
  • Countries: Australia; Brazil; China; France; Germany; India; Indonesia; Japan; Russia; South Korea; UK; USA; Canada; Italy; Spain
  • Regions: Asia-Pacific; Western Europe; Eastern Europe; North America; South America; Middle East; Africa
  • Time series: Five years historic and ten years forecast.
  • Data: Ratios of market size and growth to related markets, GDP proportions, expenditure per capita,
  • Data segmentations: country and regional historic and forecast data, market share of competitors, market segments.
  • Sourcing and Referencing: Data and analysis throughout the report is sourced using end notes.
  • Delivery format: PDF, Word and Excel Data Dashboard.

Table of Contents

1. Executive Summary

2. Kidney Biopsy Market Characteristics

3. Kidney Biopsy Market Trends And Strategies

4. Kidney Biopsy Market - Macro Economic Scenario Including The Impact Of Interest Rates, Inflation, Geopolitics, Covid And Recovery On The Market

5. Global Kidney Biopsy Growth Analysis And Strategic Analysis Framework

  • 5.1. Global Kidney Biopsy PESTEL Analysis (Political, Social, Technological, Environmental and Legal Factors, Drivers and Restraints)
  • 5.2. Analysis Of End Use Industries
  • 5.3. Global Kidney Biopsy Market Growth Rate Analysis
  • 5.4. Global Kidney Biopsy Historic Market Size and Growth, 2019 - 2024, Value ($ Billion)
  • 5.5. Global Kidney Biopsy Forecast Market Size and Growth, 2024 - 2029, 2034F, Value ($ Billion)
  • 5.6. Global Kidney Biopsy Total Addressable Market (TAM)

6. Kidney Biopsy Market Segmentation

  • 6.1. Global Kidney Biopsy Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Percutaneous Biopsy
  • Surgical Biopsy
  • 6.2. Global Kidney Biopsy Market, Segmentation By Indication, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Kidney Failure
  • Kidney Transplant
  • Hematuria
  • Proteinuria
  • 6.3. Global Kidney Biopsy Market, Segmentation By End-User, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Hospitals And Clinics
  • Urology Centers
  • Tertiary Care Centers
  • Other End-Users
  • 6.4. Global Kidney Biopsy Market, Sub-Segmentation Of Percutaneous Biopsy, By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Ultrasound-Guided Biopsy
  • CT-Guided Biopsy
  • MRI-Guided Biopsy
  • 6.5. Global Kidney Biopsy Market, Sub-Segmentation Of Surgical Biopsy, By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Open Kidney Biopsy
  • Laparoscopic Kidney Biopsy

7. Kidney Biopsy Market Regional And Country Analysis

  • 7.1. Global Kidney Biopsy Market, Split By Region, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 7.2. Global Kidney Biopsy Market, Split By Country, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

8. Asia-Pacific Kidney Biopsy Market

  • 8.1. Asia-Pacific Kidney Biopsy Market Overview
  • Region Information, Market Information, Background Information, Government Initiatives, Regulations, Regulatory Bodies, Major Associations, Taxes Levied, Corporate Tax Structure, Investments, Major Companies
  • 8.2. Asia-Pacific Kidney Biopsy Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 8.3. Asia-Pacific Kidney Biopsy Market, Segmentation By Indication, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 8.4. Asia-Pacific Kidney Biopsy Market, Segmentation By End-User, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

9. China Kidney Biopsy Market

  • 9.1. China Kidney Biopsy Market Overview
  • 9.2. China Kidney Biopsy Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F,$ Billion
  • 9.3. China Kidney Biopsy Market, Segmentation By Indication, Historic and Forecast, 2019-2024, 2024-2029F, 2034F,$ Billion
  • 9.4. China Kidney Biopsy Market, Segmentation By End-User, Historic and Forecast, 2019-2024, 2024-2029F, 2034F,$ Billion

10. India Kidney Biopsy Market

  • 10.1. India Kidney Biopsy Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 10.2. India Kidney Biopsy Market, Segmentation By Indication, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 10.3. India Kidney Biopsy Market, Segmentation By End-User, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

11. Japan Kidney Biopsy Market

  • 11.1. Japan Kidney Biopsy Market Overview
  • 11.2. Japan Kidney Biopsy Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 11.3. Japan Kidney Biopsy Market, Segmentation By Indication, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 11.4. Japan Kidney Biopsy Market, Segmentation By End-User, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

12. Australia Kidney Biopsy Market

  • 12.1. Australia Kidney Biopsy Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 12.2. Australia Kidney Biopsy Market, Segmentation By Indication, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 12.3. Australia Kidney Biopsy Market, Segmentation By End-User, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

13. Indonesia Kidney Biopsy Market

  • 13.1. Indonesia Kidney Biopsy Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 13.2. Indonesia Kidney Biopsy Market, Segmentation By Indication, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 13.3. Indonesia Kidney Biopsy Market, Segmentation By End-User, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

14. South Korea Kidney Biopsy Market

  • 14.1. South Korea Kidney Biopsy Market Overview
  • 14.2. South Korea Kidney Biopsy Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 14.3. South Korea Kidney Biopsy Market, Segmentation By Indication, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 14.4. South Korea Kidney Biopsy Market, Segmentation By End-User, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

15. Western Europe Kidney Biopsy Market

  • 15.1. Western Europe Kidney Biopsy Market Overview
  • 15.2. Western Europe Kidney Biopsy Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 15.3. Western Europe Kidney Biopsy Market, Segmentation By Indication, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 15.4. Western Europe Kidney Biopsy Market, Segmentation By End-User, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

16. UK Kidney Biopsy Market

  • 16.1. UK Kidney Biopsy Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 16.2. UK Kidney Biopsy Market, Segmentation By Indication, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 16.3. UK Kidney Biopsy Market, Segmentation By End-User, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

17. Germany Kidney Biopsy Market

  • 17.1. Germany Kidney Biopsy Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 17.2. Germany Kidney Biopsy Market, Segmentation By Indication, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 17.3. Germany Kidney Biopsy Market, Segmentation By End-User, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

18. France Kidney Biopsy Market

  • 18.1. France Kidney Biopsy Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 18.2. France Kidney Biopsy Market, Segmentation By Indication, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 18.3. France Kidney Biopsy Market, Segmentation By End-User, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

19. Italy Kidney Biopsy Market

  • 19.1. Italy Kidney Biopsy Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 19.2. Italy Kidney Biopsy Market, Segmentation By Indication, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 19.3. Italy Kidney Biopsy Market, Segmentation By End-User, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

20. Spain Kidney Biopsy Market

  • 20.1. Spain Kidney Biopsy Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 20.2. Spain Kidney Biopsy Market, Segmentation By Indication, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 20.3. Spain Kidney Biopsy Market, Segmentation By End-User, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

21. Eastern Europe Kidney Biopsy Market

  • 21.1. Eastern Europe Kidney Biopsy Market Overview
  • 21.2. Eastern Europe Kidney Biopsy Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 21.3. Eastern Europe Kidney Biopsy Market, Segmentation By Indication, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 21.4. Eastern Europe Kidney Biopsy Market, Segmentation By End-User, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

22. Russia Kidney Biopsy Market

  • 22.1. Russia Kidney Biopsy Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 22.2. Russia Kidney Biopsy Market, Segmentation By Indication, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 22.3. Russia Kidney Biopsy Market, Segmentation By End-User, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

23. North America Kidney Biopsy Market

  • 23.1. North America Kidney Biopsy Market Overview
  • 23.2. North America Kidney Biopsy Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 23.3. North America Kidney Biopsy Market, Segmentation By Indication, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 23.4. North America Kidney Biopsy Market, Segmentation By End-User, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

24. USA Kidney Biopsy Market

  • 24.1. USA Kidney Biopsy Market Overview
  • 24.2. USA Kidney Biopsy Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 24.3. USA Kidney Biopsy Market, Segmentation By Indication, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 24.4. USA Kidney Biopsy Market, Segmentation By End-User, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

25. Canada Kidney Biopsy Market

  • 25.1. Canada Kidney Biopsy Market Overview
  • 25.2. Canada Kidney Biopsy Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 25.3. Canada Kidney Biopsy Market, Segmentation By Indication, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 25.4. Canada Kidney Biopsy Market, Segmentation By End-User, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

26. South America Kidney Biopsy Market

  • 26.1. South America Kidney Biopsy Market Overview
  • 26.2. South America Kidney Biopsy Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 26.3. South America Kidney Biopsy Market, Segmentation By Indication, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 26.4. South America Kidney Biopsy Market, Segmentation By End-User, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

27. Brazil Kidney Biopsy Market

  • 27.1. Brazil Kidney Biopsy Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 27.2. Brazil Kidney Biopsy Market, Segmentation By Indication, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 27.3. Brazil Kidney Biopsy Market, Segmentation By End-User, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

28. Middle East Kidney Biopsy Market

  • 28.1. Middle East Kidney Biopsy Market Overview
  • 28.2. Middle East Kidney Biopsy Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 28.3. Middle East Kidney Biopsy Market, Segmentation By Indication, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 28.4. Middle East Kidney Biopsy Market, Segmentation By End-User, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

29. Africa Kidney Biopsy Market

  • 29.1. Africa Kidney Biopsy Market Overview
  • 29.2. Africa Kidney Biopsy Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 29.3. Africa Kidney Biopsy Market, Segmentation By Indication, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 29.4. Africa Kidney Biopsy Market, Segmentation By End-User, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

30. Kidney Biopsy Market Competitive Landscape And Company Profiles

  • 30.1. Kidney Biopsy Market Competitive Landscape
  • 30.2. Kidney Biopsy Market Company Profiles
    • 30.2.1. Cardinal Health Overview, Products and Services, Strategy and Financial Analysis
    • 30.2.2. Pfizer Inc. Overview, Products and Services, Strategy and Financial Analysis
    • 30.2.3. Merck & Co. Inc. Overview, Products and Services, Strategy and Financial Analysis
    • 30.2.4. Thermo Fisher Scientific Inc. Overview, Products and Services, Strategy and Financial Analysis
    • 30.2.5. AstraZeneca Overview, Products and Services, Strategy and Financial Analysis

31. Kidney Biopsy Market Other Major And Innovative Companies

  • 31.1. Medtronic
  • 31.2. Siemens Healthcare Private Limited
  • 31.3. Becton, Dickinson and Company
  • 31.4. Stryker Healthcare
  • 31.5. Baxter International Inc.
  • 31.6. Boston Scientific Corporation
  • 31.7. F. Hoffmann-La Roche Ltd.
  • 31.8. Zimmer Biomet
  • 31.9. Agilent Technologies Inc.
  • 31.10. Olympus Corporation
  • 31.11. Hitachi High-Tech Corporation
  • 31.12. Beckman Coulter Inc.
  • 31.13. B. Braun
  • 31.14. Sysmex Corporation
  • 31.15. Cook Medical

32. Global Kidney Biopsy Market Competitive Benchmarking And Dashboard

33. Key Mergers And Acquisitions In The Kidney Biopsy Market

34. Recent Developments In The Kidney Biopsy Market

35. Kidney Biopsy Market High Potential Countries, Segments and Strategies

  • 35.1 Kidney Biopsy Market In 2029 - Countries Offering Most New Opportunities
  • 35.2 Kidney Biopsy Market In 2029 - Segments Offering Most New Opportunities
  • 35.3 Kidney Biopsy Market In 2029 - Growth Strategies
    • 35.3.1 Market Trend Based Strategies
    • 35.3.2 Competitor Strategies

36. Appendix

  • 36.1. Abbreviations
  • 36.2. Currencies
  • 36.3. Historic And Forecast Inflation Rates
  • 36.4. Research Inquiries
  • 36.5. The Business Research Company
  • 36.6. Copyright And Disclaimer